Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-13

FDA Approved: THEOPHYLLINE — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approves Ajanta Pharma USA's Theophylline as an original (generic) application; Theophylline is a bronchodilator for reversible airway obstruction in asthma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Theophylline (Theophylline)

Snippet

ORIG AP for THEOPHYLLINE (THEOPHYLLINE)